Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
NCT06595966 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-09-19
Summary
This study will include 80 subjects after radical breast cancer resection, collect blood samples of the above subjects, observe and quantify the characteristic changes of cfDNA in the blood of breast cancer subjects after surgery, and establish a computational biological model based on next generation sequencing to monitor breast cancer MRD;
Conditions
- Breast Cancer
- Measurable Residual Disease
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2026-06-01
- Completion
- 2026-06-01
Countries
- China
Study Locations
More Related Trials
-
Genetic Alteration After Systemic Treatment in Breast Cancer
NCT02591966 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 ·Status: UNKNOWN
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
Exploring a Breast Cancer Early Screening Model Based on cfDNA
NCT06016790 ·Status: COMPLETED
-
Breast Cancer Survivorship Biorepository
NCT05786664 ·Status: RECRUITING
-
Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 ·Status: UNKNOWN
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients
NCT02669745 ·Status: COMPLETED
-
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039 ·Status: RECRUITING
-
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
NCT06087120 ·Status: RECRUITING
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262 ·Status: RECRUITING
-
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
NCT06876610 ·Status: RECRUITING
-
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
NCT06718010 ·Status: RECRUITING
-
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
NCT07025785 ·Status: RECRUITING ·Phase: NA
-
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer
NCT01247480 ·Status: UNKNOWN
-
Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer
NCT02670668 ·Status: UNKNOWN ·Phase: NA
-
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT06544668 ·Status: NOT_YET_RECRUITING
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study
NCT05444647 ·Status: UNKNOWN
-
The Study on the Clinical Utility of Liquid Biopsy in Breast Cancer
NCT02902991 ·Status: UNKNOWN
-
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
NCT01027767 ·Status: COMPLETED
-
Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer
NCT03786575 ·Status: UNKNOWN ·Phase: NA
-
Recurrence Risk Evaluation by 21-gene Detection
NCT03841266 ·Status: COMPLETED